1 year return (CAGR)
19.00%
Denali Therapeutics Inc Exchange (NASDAQ, USD)
DNLI
18.94
+0.07 (+0.36%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
1.04%
5 year return (CAGR)
-15.49%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
3.08B
Price/Sales
855.57
Ent value
3.20B
Price/Book
3.69
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 18.92 |
| Daily high | 19.29 |
| Daily low | 18.84 |
| Daily Volume | 1.58M |
| All-time high | 93.56 |
| 1y analyst estimate | 36.06 |
| Beta | 1.00 |
| EPS (TTM) | -2.73 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| DNLI | S&P500 | |
| Current price drop from All-time high | -79.76% | -3.00% |
| Highest price drop | -87.74% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -52.55% | -10.65% |
| Avg time to new high | 51 days | 12 days |
| Max time to new high | 1469 days | 1805 days |
News
